What You Need to Know About the Aardvark Therapeutics Lawsuit Investors who purchased shares of Aardvark Therapeutics, Inc. (NASDAQ: AARD) recently may be eligible to participate in a securities fraud class action lawsuit. A formal notice has been issued advising shareholders who suffered financial losses to consider their legal options regarding potential lead plaintiff roles.…